Max Healthcare Institute growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+19.2%+22.4%
EBITDA+21.3%+21.8%
Net Income+34.1%+9.3%
EPS (adj.)+34.1%+9.3%
Total Assets+13.3%+19.5%
Total Equity+14.6%+13.2%
Free Cash Flow−69.9%−44.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MAXHEALTH₹851.15

Max Healthcare Institute Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISMEDANTADRREDDYCIPLASUNPHARMADIVISLABTORNTPHARMMcap ₹82,828 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+19.2+22.4
EBITDA+21.3+21.8
Net Income+34.1+9.3
EPS (adj.)+34.1+9.3
Total Assets+13.3+19.5
Total Equity+14.6+13.2
Free Cash Flow-69.9-44.6
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.